UBcare. Co. Ltd (032620) - Cash Flow Conversion Efficiency
Based on the latest financial reports, UBcare. Co. Ltd (032620) has a cash flow conversion efficiency ratio of 0.016x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.51 Billion ≈ $1.70 Million USD) by net assets (₩158.89 Billion ≈ $107.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
UBcare. Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how UBcare. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 032620 liabilities breakdown for a breakdown of total debt and financial obligations.
UBcare. Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UBcare. Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BriQ Properties Real Estate Investment Company
AT:BRIQ
|
0.005x |
|
Innoviz Technologies
NASDAQ:INVZ
|
-0.153x |
|
PT Indonesia Kendaraan Terminal Tbk
JK:IPCC
|
0.066x |
|
Uno&Company.Ltd
KQ:114630
|
0.013x |
|
Multitude SE
LSE:0R4W
|
0.115x |
|
Heidelberg Pharma AG
F:HPHA
|
-0.299x |
|
Syrah Resources Ltd
AU:SYR
|
-0.089x |
|
Venus Remedies Limited
NSE:VENUSREM
|
0.136x |
Annual Cash Flow Conversion Efficiency for UBcare. Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of UBcare. Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see UBcare. Co. Ltd (032620) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩158.89 Billion ≈ $107.68 Million |
₩16.63 Billion ≈ $11.27 Million |
0.105x | +342.05% |
| 2024-12-31 | ₩99.22 Billion ≈ $67.24 Million |
₩2.35 Billion ≈ $1.59 Million |
0.024x | +7.93% |
| 2023-12-31 | ₩113.54 Billion ≈ $76.94 Million |
₩2.49 Billion ≈ $1.69 Million |
0.022x | -39.77% |
| 2022-12-31 | ₩116.70 Billion ≈ $79.09 Million |
₩4.25 Billion ≈ $2.88 Million |
0.036x | -45.93% |
| 2021-12-31 | ₩117.89 Billion ≈ $79.89 Million |
₩7.94 Billion ≈ $5.38 Million |
0.067x | -39.01% |
| 2020-12-31 | ₩106.52 Billion ≈ $72.19 Million |
₩11.76 Billion ≈ $7.97 Million |
0.110x | -3.89% |
| 2019-12-31 | ₩102.57 Billion ≈ $69.51 Million |
₩11.79 Billion ≈ $7.99 Million |
0.115x | +39.13% |
| 2018-12-31 | ₩101.66 Billion ≈ $68.90 Million |
₩8.40 Billion ≈ $5.69 Million |
0.083x | -58.86% |
| 2017-12-31 | ₩46.55 Billion ≈ $31.55 Million |
₩9.35 Billion ≈ $6.33 Million |
0.201x | +198.71% |
| 2016-12-31 | ₩46.56 Billion ≈ $31.55 Million |
₩3.13 Billion ≈ $2.12 Million |
0.067x | -60.94% |
| 2015-12-31 | ₩45.31 Billion ≈ $30.70 Million |
₩7.80 Billion ≈ $5.28 Million |
0.172x | +30.76% |
| 2014-12-31 | ₩39.49 Billion ≈ $26.76 Million |
₩5.20 Billion ≈ $3.52 Million |
0.132x | +4.66% |
| 2011-12-31 | ₩47.23 Billion ≈ $32.01 Million |
₩5.94 Billion ≈ $4.02 Million |
0.126x | -- |
About UBcare. Co. Ltd
UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more